Working… Menu

Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04250818
Recruitment Status : Active, not recruiting
First Posted : January 31, 2020
Last Update Posted : March 26, 2021
Information provided by (Responsible Party):
Alexander Philipovskiy, Texas Tech University Health Sciences Center, El Paso

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : April 2021
Estimated Study Completion Date : April 2021